These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 16899106)

  • 1. Interleukin-6: discovery of a pleiotropic cytokine.
    Kishimoto T
    Arthritis Res Ther; 2006; 8 Suppl 2(Suppl 2):S2. PubMed ID: 16899106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-6: from its discovery to clinical applications.
    Kishimoto T
    Int Immunol; 2010 May; 22(5):347-52. PubMed ID: 20410258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-6: from laboratory to bedside.
    Kishimoto T
    Clin Rev Allergy Immunol; 2005 Jun; 28(3):177-86. PubMed ID: 16129902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of IL-6 for the treatment of inflammatory diseases.
    Nishimoto N; Kishimoto T
    Curr Opin Pharmacol; 2004 Aug; 4(4):386-91. PubMed ID: 15251133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 6: from bench to bedside.
    Nishimoto N; Kishimoto T
    Nat Clin Pract Rheumatol; 2006 Nov; 2(11):619-26. PubMed ID: 17075601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapeutic implication of IL-6 blockade.
    Tanaka T; Kishimoto T
    Immunotherapy; 2012 Jan; 4(1):87-105. PubMed ID: 22150003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New therapeutic strategy for autoimmune diseases. 3) Treatment of autoimmune diseases by cytokine signal transduction inhibition].
    Nishimoto N; Yoshizaki K; Kishimoto T
    Nihon Naika Gakkai Zasshi; 1998 Sep; 87(9):1745-50. PubMed ID: 9816842
    [No Abstract]   [Full Text] [Related]  

  • 8. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical studies in patients with Castleman's disease, Crohn's disease, and rheumatoid arthritis in Japan.
    Nishimoto N
    Clin Rev Allergy Immunol; 2005 Jun; 28(3):221-30. PubMed ID: 16129906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-beta 2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines.
    Kirnbauer R; Köck A; Schwarz T; Urbanski A; Krutmann J; Borth W; Damm D; Shipley G; Ansel JC; Luger TA
    J Immunol; 1989 Mar; 142(6):1922-8. PubMed ID: 2784142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene of the month: Interleukin 6 (IL-6).
    Ataie-Kachoie P; Pourgholami MH; Richardson DR; Morris DL
    J Clin Pathol; 2014 Nov; 67(11):932-7. PubMed ID: 25031389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
    Woolley DE; Tetlow LC
    Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-6/IL-6 receptor system and its role in physiological and pathological conditions.
    Mihara M; Hashizume M; Yoshida H; Suzuki M; Shiina M
    Clin Sci (Lond); 2012 Feb; 122(4):143-59. PubMed ID: 22029668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis.
    Nowell MA; Richards PJ; Fielding CA; Ognjanovic S; Topley N; Williams AS; Bryant-Greenwood G; Jones SA
    Arthritis Rheum; 2006 Jul; 54(7):2084-95. PubMed ID: 16802343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6.
    Tosato G; Gerrard TL; Goldman NG; Pike SE
    J Immunol; 1988 Jun; 140(12):4329-36. PubMed ID: 2836512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 6 (IL-6) and its receptor: their role in plasma cell neoplasias.
    Hirano T
    Int J Cell Cloning; 1991 May; 9(3):166-84. PubMed ID: 2061619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Basic and clinical aspects of IL-6].
    Nakajima K; Hirano T
    Gan To Kagaku Ryoho; 1991 Apr; 18(4):505-14. PubMed ID: 1707253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances in interleukin-6 therapy].
    Ogata A; Nishimoto N; Yoshizaki K
    Rinsho Byori; 1999 Apr; 47(4):321-6. PubMed ID: 10340005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-6 signal transduction and its physiological roles: the signal orchestration model.
    Kamimura D; Ishihara K; Hirano T
    Rev Physiol Biochem Pharmacol; 2003; 149():1-38. PubMed ID: 12687404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.